Clinical Trials List
2022-02-12 - 2025-09-30
Phase II
Not yet recruiting1
Terminated5
ICD-10C79.00
Secondary malignant neoplasm of unspecified kidney and renal pelvis
ICD-10C79.01
Secondary malignant neoplasm of right kidney and renal pelvis
ICD-10C79.02
Secondary malignant neoplasm of left kidney and renal pelvis
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9198.0
Secondary malignant neoplasm of kidney
-
Trial Applicant
Pharmaceutical Research Associates Taiwan Inc.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 廖斌志 無
- 陳冠宇 無
- 蔡子修 無
- Jih-Hsiang Lee 無
- JIN-YUAN SHIH 無
- 許嘉林 無
- YEN-TING LIN 無
- 徐偉勛 無
- CHAO-CHI HO CHAO-CHI HO 無
- 楊景堯 無
- Chia-Chi Lin 無
- Chong-Jen Yu 無
- 廖唯昱 無
- 吳尚俊 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yu-Fang Huang 無
- Wu-Chou Su 無
- Chien-Chung Lin 無
- Chia-Jui Yen 無
- Shang-Yin Wu 無
- Yu-Min Yeh 無
- Wen-Pin Su 無
- Jui-Hung Tsai 無
- Po-Lan Su 無
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 吳仁欽 無
- 張淑涵 無
- 黃彥綾 無
- Angel Chao 無
- Ting-Chang Chang 無
- HSIU-JUNG TUNG 無
- 周宏學 無
- 陳威君 無
- 黃寬仁 無
- Chyong-Huey Lai 無
- Cheng-Tao Lin 無
- Min-Yu Chen 無
- Huei-Jean Huang 無
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
652 participants
